Please use this identifier to cite or link to this item: https://doi.org/10.1126/scitranslmed.3006086
Title: Genome-wide mutational signatures of aristolochic acid and its application as a screening tool
Authors: Poon, S.L.
Pang, S.-T.
McPherson, J.R.
Yu, W.
Huang, K.K.
Guan, P.
Weng, W.-H.
Siew, E.Y.
Liu, Y.
Heng, H.L.
Chong, S.C.
Gan, A.
Tay, S.T.
Lim, W.K.
Cutcutache, I. 
Huang, D.
Ler, L.D.
Nairismägi, M.-L.
Lee, M.H.
Chang, Y.-H.
Yu, K.-J.
Chan-On, W.
Li, B.-K.
Yuan, Y.-F.
Qian, C.-N.
Ng, K.-F.
Wu, C.-F.
Hsu, C.-L.
Bunte, R.M. 
Stratton, M.R.
Andrew Futreal, P.
Sung, W.-K. 
Chuang, C.-K.
Ong, C.K.
Rozen, S.G. 
Tan, P. 
Teh, B.T.
Issue Date: 7-Aug-2013
Source: Poon, S.L., Pang, S.-T., McPherson, J.R., Yu, W., Huang, K.K., Guan, P., Weng, W.-H., Siew, E.Y., Liu, Y., Heng, H.L., Chong, S.C., Gan, A., Tay, S.T., Lim, W.K., Cutcutache, I., Huang, D., Ler, L.D., Nairismägi, M.-L., Lee, M.H., Chang, Y.-H., Yu, K.-J., Chan-On, W., Li, B.-K., Yuan, Y.-F., Qian, C.-N., Ng, K.-F., Wu, C.-F., Hsu, C.-L., Bunte, R.M., Stratton, M.R., Andrew Futreal, P., Sung, W.-K., Chuang, C.-K., Ong, C.K., Rozen, S.G., Tan, P., Teh, B.T. (2013-08-07). Genome-wide mutational signatures of aristolochic acid and its application as a screening tool. Science Translational Medicine 5 (197) : -. ScholarBank@NUS Repository. https://doi.org/10.1126/scitranslmed.3006086
Abstract: Aristolochic acid (AA), a natural product of Aristolochia plants found in herbal remedies and health supplements, is a group 1 carcinogen that can cause nephrotoxicity and upper urinary tract urothelial cell carcinoma (UTUC). Whole-genome and exome analysis of nine AA-associated UTUCs revealed a strikingly high somatic mutation rate (150 mutations/Mb), exceeding smoking-associated lung cancer (8 mutations/Mb) and ultraviolet radiation-associated melanoma (111 mutations/Mb). The AA-UTUC mutational signature was characterized by A:T to T:A transversions at the sequence motif A[C|T]AGG, located primarily on nontranscribed strands. AA-induced mutations were also significantly enriched at splice sites, suggesting a role for splice-site mutations in UTUC pathogenesis. RNA sequencing of AA-UTUC confirmed a general up-regulation of nonsense-mediated decay machinery components and aberrant splicing events associated with splice-site mutations. We observed a high frequency of somatic mutations in chromatin modifiers, particularly KDM6A, in AA-UTUC, demonstrated the sufficiency of AA to induce renal dysplasia in mice, and reproduced the AA mutational signature in experimentally treated human renal tubular cells. Finally, exploring other malignancies that were not known to be associated with AA, we screened 93 hepatocellular carcinoma genomes/exomes and identified AA-like mutational signatures in 11. Our study highlights an unusual genome-wide AA mutational signature and the potential use of mutation signatures as "molecular fingerprints" for interrogating high-throughput cancer genome data to infer previous carcinogen exposures. Copyright 2013 by the American Association for the Advancement of Science.
Source Title: Science Translational Medicine
URI: http://scholarbank.nus.edu.sg/handle/10635/53439
ISSN: 19466234
DOI: 10.1126/scitranslmed.3006086
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

100
checked on Dec 13, 2017

WEB OF SCIENCETM
Citations

56
checked on Nov 14, 2017

Page view(s)

70
checked on Dec 16, 2017

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.